ClinicalTrials.gg
RecruitingNCT07775937Updated Aug 20, 2026

Social Robots and Board Games for Children With Autism Spectrum Disorder

An interventional study of Social Robot-Assisted Board Game Intervention and Conventional Occupational Therapy in Autism Spectrum Disorder and Child Development Disorders, Pervasive, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 4 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-08-20.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
4 Years to 10 Years
Sex
All
01

Study summary

This pilot randomized controlled trial evaluates the effectiveness of combining social robot-assisted intervention with physical board games to improve socio-emotional skills in children with Autism Spectrum Disorder (ASD).

Children with ASD often face challenges in emotion recognition, emotional regulation, and social interaction. This study aims to investigate whether integrating an interactive social robot (Kebbi) into board game activities can enhance children's social engagement, emotional comprehension, and cooperative behaviors compared to conventional occupational therapy. Participants will be randomly assigned to either the robot-assisted board game group or the conventional occupational therapy group.

Read the detailed description

BACKGROUND AND OBJECTIVES:

Children with Autism Spectrum Disorder (ASD) often encounter challenges in emotion recognition, emotional regulation, and social interactions. This pilot randomized controlled trial investigates the preliminary efficacy and feasibility of integrating a commercially available interactive social robot (Kebbi Air) with customized physical acrylic board games to enhance socio-emotional functioning in children with ASD, compared to conventional occupational therapy.

INTERVENTION PROTOCOL:

Participants are randomly allocated into one of two 8-week intervention programs (1 session per week, 30 minutes per session):

  1. Experimental Group (Robot-Assisted Board Game Intervention):

    Participants interact with the Kebbi Air social robot running a dedicated application developed in collaboration with digital media specialists. The curriculum comprises 14 structured social scenarios addressing basic emotion recognition (happiness, anger, sadness, fear, liking, jealousy, longing), appropriate social responses, and non-verbal cues. The robot utilizes facial expressions, body movements, and dynamic voice cues to present 10 interactive questions per script. Children collect 5 modular acrylic puzzle pieces per scenario representing body postures, clothing, dialogue, background, and objects, assembling them onto an emotion puzzle board. A certified occupational therapist facilitates the session by scaffolding comprehension and guiding peer interactions. The robot serves purely as an interactive instructional tool and does not record or store personal identifiable data.

  2. Control Group (Conventional Occupational Therapy):

Participants receive standard, therapist-led occupational therapy targeting sensory-motor integration, emotional regulation, and social participation. Activities include sensory-based equipment (e.g., swings, therapy rollers, jumping mats) and structured social games (turn-taking, rule-following, and collaborative tasks) without robotic devices or specialized emotion puzzle board games.

OUTCOME MEASURES:

Standardized assessments are administered at baseline (pre-intervention) and immediately post-intervention (Week 8) via parent-reported questionnaires:

  • Social Responsiveness Scale, Second Edition (SRS-2) to assess social communication, social motivation, and autistic behaviors.
  • Achenbach System of Empirically Based Assessment (ASEBA) to evaluate emotional, behavioral, and adaptive competencies.

SAMPLE SIZE AND RANDOMIZATION:

A total of 20 children aged 4 to 10 years with a confirmed clinical diagnosis of ASD (and meeting CDIIT developmental criteria) will be recruited and randomized (1:1 ratio) to either the experimental or control group.

02

Conditions studied

  • Autism Spectrum Disorder
  • Child Development Disorders, Pervasive

Keywords

  • Social Robots
  • Board Games
  • Occupational Therapy
  • Socio-Emotional Skills
  • Emotion Recognition
03

In context

Autism Spectrum Disorder

1,724 studies on the registry are indexed under Autism Spectrum Disorder; 500 are open to participants now.

This study's planned enrollment of 20 is below the median of 52 across 1,368 interventional studies indexed under Autism Spectrum Disorder.

Browse Autism Spectrum Disorder studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,615 studies on the registry; 576 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children aged 4 to 10 years, of any biological sex.
  2. Confirmed clinical diagnosis of Autism Spectrum Disorder (ASD).
  3. Cognitive ability: Comprehensive Developmental Inventory for Infants and Toddlers (CDIIT) results indicating borderline to normal cognitive function, with a Developmental Quotient (DQ) >= 70.
  4. Socio-emotional ability: CDIIT socio-emotional subscale indicating borderline development, with a Developmental Quotient (DQ) between 70 and 84.
  5. Legal guardian provides written and child provides assent where appropriate.

Exclusion criteria

Exclusion Criteria:

  1. Inability to comprehend or engage in interactive activities involving the Kebbi Air robot or physical board games.
  2. Presence of other primary diagnoses affecting emotional or social functioning, such as severe neurodevelopmental disorders, psychiatric disorders, or ASD with severe emotional disturbances that prevent participation in intervention activities (CDIIT DQ \< 70).
  3. Inability to commit to regular weekly intervention sessions, or parental unwillingness to participate in required observational assessments and questionnaire completion.
  4. Strong behavioral resistance or severe aversion to digital interactive tools or board game activities.
  5. Inability to follow simple two-step verbal instructions after a preliminary 10-minute trial assessment conducted by the occupational therapist.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Robot-Assisted Board Game Group

    Participants receive an 8-week social robot-assisted intervention combined with physical acrylic emotion puzzle board games (1 session per week, 30 minutes per session), facilitated by a certified occupational therapist.

    Behavioral: Social Robot-Assisted Board Game Intervention

  • Active comparator
    Conventional Occupational Therapy Group

    Conventional Occupational Therapy Group

    Behavioral: Conventional Occupational Therapy

Interventions

  • BehavioralSocial Robot-Assisted Board Game Intervention

    Comprises 14 structured social-emotional scenario scripts using the Kebbi Air interactive robot and a custom mobile application, paired with 5-piece modular acrylic emotion puzzle boards covering 7 basic and complex emotions.

  • BehavioralConventional Occupational Therapy

    Standard occupational therapy utilizing sensory integration equipment (e.g., swings, therapy rollers, jumping mats) and therapist-guided social interactive activities targeting emotional regulation and peer interaction.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Social Responsiveness Scale, Second Edition (SRS-2) Total T-Score at Week 8

    The SRS-2 is a 65-item parent-reported questionnaire evaluating social communication, social motivation, and autistic behaviors in children. Items are rated on a 4-point Likert scale. Raw scores are converted to standardized T-scores (mean = 50, SD = 10). Higher T-scores indicate more severe social responsiveness impairment (T-scores ≥ 60 indicate clinically significant impairment). Outcome is assessed as the score change from baseline to post-intervention (Week 8).

    Time frame: Baseline (pre-intervention) and post-intervention at Week 8

Secondary outcomes

  1. Change from Baseline in Achenbach System of Empirically Based Assessment (ASEBA) Total Problems T-Score at Week 8

    The ASEBA (Child Behavior Checklist) is a standardized parent-completed instrument assessing emotional, behavioral, and social adaptive competencies. Raw scores yield standardized T-scores for internalizing, externalizing, and total behavioral problems (mean = 50, SD = 10). Higher T-scores indicate greater behavioral or emotional difficulties (T-scores ≥ 64 indicate clinical concern). Outcome is assessed as the score change from baseline to post-intervention (Week 8).

    Time frame: Baseline (pre-intervention) and post-intervention at Week 8

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07775937
Responsible party
Sponsor
First posted
Aug 20, 2026
Start date
Aug 18, 2026
Primary completion
Nov 30, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 20, 2026

Study contacts

LIAO SHUYI, MS
Contact
kukocliao@gmail.com
+886-5-6330002#574322

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion